MDS Nordion
|
447 March Road
Contact Person
Shelley Maclean
|
Company Description
MDS Nordion is a world leader in providing isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies.MDS Nordion provides:
- Scientific and technology leadership to supply isotopes for cardiac imaging, targeted cancer treatments and sterilization of medical products
- Unique collaborations to bring novel molecular imaging agents and radiotherapeutics to market
- Highly specialized expertise in the operation and logistics of medical isotopes
Products
- TheraSphere®
TheraSphere®, Yttrium-90 glass microspheres, is a technologically advanced form of brachytherapy. It is CE marked in Europe for use in the treatment of hepatic neoplasia.
Description of Principle
TheraSphere®,a localized, minimally embolic therapy, capitalizes on the hypervasculature nature of tumors delivering yttrium-90 microspheres, a source of beta energy, via the hepatic artery to the tumor bed. The distribution of blood flow is 3 to 7 times greater within the tumor than the surrounding noncancerous tissue. Consequently, there is preferential delivery of microspheres to the tumor capillary bed allowing for higher doses of radiation to be delivered to the tumor relative to the surrounding nontumor parenchyma. The presence of portal vein thrombosis (PVT) is a contraindication for most embolic therapies whereas TheraSphere® represents a safe treatment in this patient population who would otherwise have no options.
Scientific Information
TheraSphere® publications are specific to the regulatory approvals within your geographic region. Select a geographic region from the following link, then scroll down for information relevant to the TheraSphere indication your territory.
more...